REQUEST A DEMO
Total
USD $0.00
Search more companies

Hematologia Y Oncologia Del Oriente Sas (Colombia)

Main Activities: General Medical and Surgical Hospitals
Secondary Activities: Ambulatory Health Care Services | Other Ambulatory Health Care Services | Nursing Care Facilities (Skilled Nursing Facilities)
Full name: Hematologia Y Oncologia Del Oriente Sas Profile Updated: January 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Hematologia Y Oncologia Del Oriente Sas is based in Colombia. The head office is in Yopal. It operates in the General Medical and Surgical Hospitals industry. The company was established on December 20, 2014. From the latest financial highlights, Hematologia Y Oncologia Del Oriente Sas reported a net sales revenue increase of 34.8% in 2025. Its’ total assets recorded a growth of 60.39%. The net profit margin of Hematologia Y Oncologia Del Oriente Sas increased by 16.09% in 2025.

Headquarters
Carrera 23 N. 12 - 15 Local 1 Sede Especia
Yopal; Casanare;

Contact Details: Purchase the Hematologia Y Oncologia Del Oriente Sas report to view the information.

Basic Information
Registered Capital:
Purchase the Hematologia Y Oncologia Del Oriente Sas report to view the information.
Financial Auditors:
Purchase the Hematologia Y Oncologia Del Oriente Sas report to view the information.
Incorporation Date:
December 20, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Hematologia Y Oncologia Del Oriente Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
34.8%
Total Operating Revenue
34.8%
Operating Profit
147.53%
EBITDA
143.88%
Net Profit/Loss for the Period
344.57%
Total Assets
60.39%
Total Equity
114.4%
Operating Profit Margin
12.03%
Net Profit Margin
16.09%
Return on Equity (ROE)
27.63%
Debt / Equity
-1.65%
Quick Ratio
0.33%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?